02.11.2016 Views

CORRUPTION

2f8yK1Y

2f8yK1Y

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

International Affairs Forum Fall 2016<br />

Interview with Professor Susanne Lundin<br />

Lund University<br />

As an expert on organ trafficking, could you<br />

evaluate the scale to which it is a global<br />

issue?<br />

Background. Worldwide, transplantations should<br />

be altruistic donations. Commercial transactions<br />

are not allowed: The organ should be a gift. One<br />

exception is Iran. Since 1988, Iran has operated<br />

the only government-sponsored paid living donor<br />

(LD) kidney transplant program.<br />

Transplants from deceased donors involve<br />

solid organs, including the heart, lungs, liver,<br />

kidney, and pancreas. It is also possible to<br />

receive transplants from living individuals: A<br />

living person can donate a single kidney or a<br />

piece of his or her liver. Most living transplants<br />

involve the kidney, since a human being has two<br />

kidneys and is able to live with only one. In many<br />

countries worldwide, the demand for organs from<br />

both deceased and living donors far outstrips<br />

the supply. This can be caused by many things,<br />

including poor dissemination of information to<br />

citizens regarding transplantation and donation,<br />

poor organization in healthcare, and political<br />

and cultural reasons. The latter may be due to<br />

the fact that in many countries donation from the<br />

deceased, normally the largest donation group,<br />

does not exist because of cultural and religious<br />

reasons.<br />

While the increased availability of organs<br />

resulting from living donation is beneficial,<br />

the possible subsequent trade of organs is<br />

disadvantageous. Another double-edged benefit<br />

is the immunosuppressant drug, Cyclosporine,<br />

which was introduced in the early 1980s. Until<br />

then, a problem in transplantation medicine was<br />

that the body often rejected foreign body parts,<br />

a process that changed dramatically with the<br />

help of immunosuppressant drugs and meant<br />

that the recipients of organs had significantly<br />

better chances of keeping an organ than before.<br />

However, this also meant that there were more<br />

opportunities to use organs from people whose<br />

blood type did not necessarily match that of the<br />

sick recipient. This was and is one of various<br />

important factors that facilitate trade in organs<br />

and make it easy for individuals to become<br />

victims of coercion.<br />

Illegal trade. There are numerous cases where<br />

the so-called “informed consent” document,<br />

necessary for all transplantations, lures<br />

disadvantaged people into a commercial<br />

transaction in which they usually get only an<br />

insignificant amount of money, or nothing at all.<br />

Poor and vulnerable people can become victims<br />

of wealthy patients who require organs to stay<br />

alive. The exploitation and vulnerability of the<br />

organ suppliers are manifested by the fact that<br />

they receive little or no payment at all. Organ<br />

selling does not lead to long-term economic<br />

benefits since selling a kidney is associated with<br />

a decline in health status and a diminished ability<br />

to return to labor-intensive work. In fact, selling a<br />

kidney may worsen the seller’s economic status.<br />

Buyers. They pay between US$100,000 and<br />

US$250,000 for a kidney.<br />

Fall 2016<br />

117

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!